Navigation Links
Safer nanoparticles spotlight tumors, deliver drugs
Date:2/22/2009

Small is promising when it comes to illuminating tiny tumors or precisely delivering drugs, but many worry about the safety of nano-scale materials. Now a team of scientists has created miniscule flakes of silicon that glow brightly, last long enough to slowly release cancer drugs, then break down into harmless by-products.

"It is the first luminescent nanoparticle that was purposely designed to minimize toxic side effects," said Michael Sailor, a chemistry professor at the University of California, San Diego who led the study.

Many nanoparticles tested in research labs are too poisonous for use in humans.

"This new design meets a growing need for non-toxic alternatives that have a chance to make it into the clinic to treat human patients," Sailor said.

The particles inherently glow, a useful property that is most commonly achieved by including toxic organic chemicals or tiny structures called quantum dots, which can leave potentially harmful heavy metals in their wake.

When the researchers tested their safer nanoparticles in mice, they saw tumors glow for several hours, then dim as the particles broke down. Levels dropped noticeably in a week and were undetectable after four weeks, they report in Nature Materials February 22.

This is the first sudy to image tumors and organs using biodegradable silicon nanoparticles in live animals, the authors say.

The particles begin as thin wafers made porous with an electrical current then smashed to bits with ultrasound. Additional treatment alters the physical structure of the flakes to make them glow red when illuminated with ultraviolet light.

Luminescent particles can reveal tumors too tiny to detect by other means or allow a surgeon to be sure all of a cancerous growth has been removed.

These nanoparticles could also help deliver drugs safely, the researchers report. The cancer drug doxorubicin will stick to the pores and slowly escape as the silicon dissolves.

"The goal is to use the nanoparticles to chaperone the drug directly to the tumor, to release it into the tumor rather than other parts of the body," Sailor said.

Targeted delivery would allow doctors to use smaller doses of the drug. At doses high enough to be effective, when delivered to the whole body, doxorubicin often has toxic side effects.

At about 100 nanometers, these particles are bigger than many designed to deliver drugs, which can be just a few nanometers across a thousand times smaller than the diameter of a human hair.

Their larger size contributes to both their effectiveness and their safety. Large particles can hold more of a drug. Yet they self-destruct, and the remnants can be filtered away by the kidneys.

Close examination of vulnerable organs like liver, spleen and kidney, which help to remove toxins, revealed no lasting changes in mice treated with the new nanoparticles.


'/>"/>

Contact: Michael Sailor
msailor@ucsd.edu
University of California - San Diego
Source:Eurekalert  

Related biology technology :

1. Developing a Safer and More Effective Way to Deliver Rabies Antibodies
2. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
3. ICU Medical Inc. and Health Robotics Announce Compatibility of CytoCare(TM) Robot and CLAVE(R) Needle-Free Connector to Enable Safer Hazardous Drug Handling
4. Safer, easier system for remote explosive detection
5. Using supercomputers to make safer nuclear reactors
6. Gold-palladium nanoparticles achieve greener, smarter production of hydrogen peroxide
7. Nanoparticles double their chances of getting into sticky situations
8. Enhancing solar cells with nanoparticles
9. Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
10. Engineering nanoparticles for maximum strength
11. NC State engineers discover nanoparticles can break on through
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Safer nanoparticles spotlight tumors, deliver drugs
(Date:3/28/2017)... ... March 28, 2017 , ... ... of a new orally administered treatment for Alzheimer’s disease (AD), today announced that ... states, “As we seek to uniquely treat the metabolic dysfunctions inherent in Alzheimer’s ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Harvill as Chief Executive Officer with Avomeen Analytical Services. Harvill is a distinguished ... and operations. , Avomeen is a leader in a wide range of ...
(Date:3/27/2017)... -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company ... foodborne pathogens,  today announced that Mary Duseau , CEO ... on March 29 at 9:50am ET. The conference will be ... About Roka Bioscience ... Roka Bioscience is a molecular diagnostics company ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... accelerating the fight against cancer, autoimmune disease and more through a single-cell precision ... metabolomics and proteomics analysis platform developed in the laboratory of Dr. James ...
Breaking Biology Technology:
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/24/2017)... , March 24, 2017 The Controller General of ... Mr. Abdulla Algeen have received the prestigious international IAIR Award ... Continue Reading ... ... and Deputy Controller Abdulla Algeen (small picture on the right) have received ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):